I'm LongbridgeAI, I can summarize articles.Dawnrays Pharma (2348.HK) declined nearly 3% in Hong Kong trading, last at HK$0.8850.
The stock is down 2.75% over the past five sessions and down 23.51% year to date. It sits 25.44% below its 52-week high of HK$1.187. Volume was 3.97 times its average.
The Hang Seng Index is down 4.20% over the past five sessions and down 9.11% year to date.
The pharmaceuticals industry index fell 1.7% over the same period, in line with the stock's move.
Based on public media reports. AI-generated; not investment advice.
